中山外痔疮图片治疗方法中山混合痔医院哪最好,中山大便出少量血,中山老人拉出血来是怎么回事,中山大便为何会出血,中山大便擦屁股时有血,中山市华都肛肠医院治疗费用,中山肛门湿诊

BEIJING, Oct. 24 (Xinhuanet) -- There is no evidence to prove that using a cell phone can increase the risks of brain cancer, suggested a lastest study by Danish researchers.To arrive at the result, the researchers examined the health records from 1990 to 2007 for 358,403 Danish cell phone plan subscribers.They found that among people using cell phones for as long as 13 years or more, the cancer risks were almost the same as for non-subscribers.The finding, published in the British Medical Journal last week, alleviated the fear among the world's 5 billion cell phone users.Five months ago, a statement from the World Health Organization's International Agency for Research on Cancer (IARC) sparked fear in cell phone users around the world because it said that cell phone use might cause brain cancer.However, the finding could not rule out the risk of brain cancer triggered by heavy use of cell phones, admitted Patrizia Frei of the Danish Cancer Society's Institute of Cancer Epidemiology, lead author of the study.Frei added, cited by CNN, "There are still some open questions, about greater amounts of use, and about the effects on children."The IARC did not give formal response to the study, but it offered some ways for cell phone consumers to reduce possible risks months ago.Texting and using hands-free sets for voice calls lower exposure to potentially harmful radiation, compared to device-to-ear voice calls, by at least 10-fold, IARC stated, reported by the New York Daily News.

BEIJING, Oct. 27 (Xinhuanet) -- Virginia M. Rometty, 54, will succeed present IBM CEO Sam Palmisano to be the next chief executive at the start of 2012, the company announced Tuesday.This is unprecedented in the New York-based company's 100-year history, because Rometty, a senior vice president of IBM, will be its first female CEO.Since joining the company three decades ago, Ms. Rometty has contributed a lot to the giant I.T. Company.After graduating from Northwestern University with an undergraduate degree in computer science, she entered the company in 1981 as a systems engineer. In virtue of outstanding performance, she was quickly promoted to management.For the following 20 years, she worked with clients in banking, insurance, and telecommunications, to name a few.In 2002, Rometty caught Palmisano's attention when she helped integrate the 3.5 billion dollar acquisition of the big business consulting firm PricewaterhouseCoopers Consulting, IBM's largest deal ever at the time.Then she became senior vice president of the group and group executive for sales, marketing and strategy in 2009. Under her leading, the business in overseas emerging markets including China, India, Brazil and several African nations, has increased sharply.New York Times reported that such markets now accounted for 23 percent of IBM.’s revenue, up from 20 percent when she took over.“Ginni got it because she deserved it,” Mr. Palmisano told the New York Times. "Ginni" is an informal first name used by her friends and colleagues.The selection of Rometty for chief executive will make her the 17th female CEO in the Fortune 500 on the following January. Other prominent women who play the same role as Rometty include Indra Nooyi of PepsiCo, Ellen J. Kullman of DuPont, Meg Whitman of Hewlett-Packard, and so on.

WASHINGTON, Nov. 16 (Xinhua) -- Supervised exercise was shown to be more effective than stenting or medication for improved walking ability in patients with peripheral artery disease (PAD), according to a U.S. study reported Wednesday at the 2011 American Heart Association Scientific Sessions meeting.The research group reported that of 111 patients studied in the randomized trial, the most effective treatment proved to be supervised exercise based on the results of a treadmill test taken at baseline and again at six months. Patients who were in the supervised exercise group improved by a mean of 4.6 minutes in the treadmill test, while the group who received stents improved by a mean of 2.5 minutes. However, researchers found that self-reported quality of life measurements proved to be higher in the group that received stents, even though their ability to walk did not improve as greatly as the group that received supervised exercise rehabilitation.The findings were published in the November issue of the journal Circulation. The researchers believe that more studies are necessary, although supervised exercise may be an effective treatment recommended for PAD patients with claudication.PAD is a condition in which plaque builds up in the arteries and affects blood flow, especially to the legs. It is estimated that between 10 and 12 million people suffer from PAD in the United States. One symptom of PAD is known as claudication, a painful cramping of the leg muscles that limits the patient's ability to walk. It affects nearly 2 million people who suffer from PAD, and results in a sedentary lifestyle and poor quality of life.Current U.S. guidelines for the treatment of claudication include pharmacotherapy, supervised exercise rehabilitation and lower extremity revascularization using stents.

YAGNON, Oct. 23 (Xinhua) -- Myanmar has launched anti-dengue high fever campaign in seven townships in Yangon simultaneously as a prevention measure against the disease, according to the Health Department Sunday.The campaign was carried out in the weekend in collaboration with health department staff and members of social organizations.Dengue preventive and control measures were occasionally launched in schools and wards in Myanmar with the aid of World Health Organization, U.N. Children Fund, three Disease Fund, Global Fund and Japan International Cooperation Agency.According to statistics, a total of 181 people died of dengue fever in Myanmar's Yangon region in the past five years alone, out of 19,000 such cases occurring in the region during the half decade.According to earlier report, the number of people infected with dengue fever in the whole country in 2009 amounted to 3,129 with 37 deaths registered.However, according to the Yangon City Development Committee, the city saw less dengue fever occurrence in 2010 with death rate reducing to one percent in the year from over six percent in 1970.Meanwhile, the Myanmar health authorities are stepping up preventive measures against dengue fever in this sensitive rainy season by extending injection to people.The authorities are also introducing medicine with better effect, combating larva, giving education talks on the prevention and control especially in markets.Dengue fever mostly infected under-15 children, especially those between three and nine years old, but now such disease had also been found among some adult people, the authorities said, warning that dengue fever occurs regardless of age and season.Myanmar, along with Indonesia and Thailand, suffers dengue outbreak most in Southeast Asia region that makes up 52 percent of the dengue-prone areas in the world.

SAN FRANCISCO, Dec. 2 (Xinhua) -- About one in 10 mobile phone subscribers in the United States is now using an Apple iPhone, said a new survey released on Friday.Latest survey results from research firm comScore showed that for the three-month period ending in October, Apple remained the No. 4 handset maker in the U.S. with its share of mobile subscribers rising to 10.8 percent from 9.5 percent in the previous three months.Among the top five mobile phone brands in the U.S. market, Apple is the only one that saw its market share increase in the quarter, according to the survey.Samsung was still the top handset manufacturer with 25.5 percent of U.S. mobile subscribers, followed by LG and Motorola taking the second and third place with 20.6 percent and 13.6 percent of share respectively.Research in Motion (RIM), maker of Blackberry, ranked No. 5 with a share of 6.6 percent.Except Apple, market shares of the other four brands remained unchanged or dropped from the previous quarter.Apple's gain in the quarter might be driven by the introduction of new model iPhone 4S which went on sale on Oct. 14, and the addition of Sprint as a carrier in the U.S. market, some analysts said.The survey by comScore, which involved more than 30,000 U.S. mobile subscribers, found that 234 million Americans age 13 and older used mobile devices by the end of October.